公司資料
Adicet Bio 股價、新聞與催化劑
- 股票代碼:
- ACET
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
8.74 USD (+4.30%)
收盤價
最後更新: 2026年8月17日
75.8M USD
市值
股價為何變動
As of Aug 17, 2026, ACET closed up 4.30% at $8.74. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Adicet Bio is a cell-therapy company focused on gamma delta T-cell therapies for cancer and immune disease. Its platform is trying to create off-the-shelf cell therapies with broader utility.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Adicet sits in advanced cell therapy.
商業模式特徵
The business depends on platform validation, manufacturing execution, and early clinical proof-of-concept.
生技產業定位
Adicet is a high-catalyst cell-therapy name whose valuation is highly sensitive to translational progress.
未來催化劑
- Adicet’s catalysts are ADI-001 and the rest of its allogeneic gamma delta CAR-T platform. The company needs clinical updates that keep the allogeneic story credible.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。